Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry G Graham

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|July 18, 2022
Population pharmacokinetic modelling of febuxostat in healthy subjects and people with goutBishoy Kamel, Ahmad Y Abuhelwa, David Foster, et al.
British Journal of Clinical Pharmacology|May 10, 2020
A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjectsBishoy Kamel, Garry G Graham, Sophie L Stocker, et al.
Biochimie|April 6, 2010
Emerging roles for phospholipase A2 enzymes in cancerKieran F Scott, Mila Sajinovic, Juliane Hein, et al.
British Journal of Clinical Pharmacology|October 8, 2014
The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitusJanna K Duong, Shaun S Kumar, Timothy J Furlong, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 28, 2019
Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detectionBishoy Kamel, Kenneth M Williams, Garry G Graham, et al.
Annals of the Rheumatic Diseases|February 3, 2016
Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urateDiluk R W Kannangara, Amanda J Phipps-Green, Nicola Dalbeth, et al.
Arthritis Research & Therapy|August 21, 2012
Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patientsDiluk R W Kannangara, Sheena N Ramasamy, Praveen L Indraratna, et al.
British Journal of Clinical Pharmacology|April 18, 2013
Understanding the dose-response relationship of allopurinol: predicting the optimal dosageGarry G Graham, Diluk R W Kannangara, Sophie L Stocker, et al.
Drug Safety|July 23, 2013
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012Sheena N Ramasamy, Cameron S Korb-Wells, Diluk R W Kannangara, et al.
British Journal of Clinical Pharmacology|April 19, 2017
Individualising the dose of allopurinol in patients with goutDiluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|July 18, 2022
Population pharmacokinetic modelling of febuxostat in healthy subjects and people with goutBishoy Kamel, Ahmad Y Abuhelwa, David Foster, et al.
British Journal of Clinical Pharmacology|May 10, 2020
A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjectsBishoy Kamel, Garry G Graham, Sophie L Stocker, et al.
Biochimie|April 6, 2010
Emerging roles for phospholipase A2 enzymes in cancerKieran F Scott, Mila Sajinovic, Juliane Hein, et al.
British Journal of Clinical Pharmacology|October 8, 2014
The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitusJanna K Duong, Shaun S Kumar, Timothy J Furlong, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 28, 2019
Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detectionBishoy Kamel, Kenneth M Williams, Garry G Graham, et al.
Annals of the Rheumatic Diseases|February 3, 2016
Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urateDiluk R W Kannangara, Amanda J Phipps-Green, Nicola Dalbeth, et al.
Arthritis Research & Therapy|August 21, 2012
Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patientsDiluk R W Kannangara, Sheena N Ramasamy, Praveen L Indraratna, et al.
British Journal of Clinical Pharmacology|April 18, 2013
Understanding the dose-response relationship of allopurinol: predicting the optimal dosageGarry G Graham, Diluk R W Kannangara, Sophie L Stocker, et al.
Drug Safety|July 23, 2013
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012Sheena N Ramasamy, Cameron S Korb-Wells, Diluk R W Kannangara, et al.
British Journal of Clinical Pharmacology|April 19, 2017
Individualising the dose of allopurinol in patients with goutDiluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
Pageof 5